[1]
Harshit Singh et al. 2018. CONFLICT BETWEEN BRAND NAME DRUGS AND THEIR GENERIC ADAPTATIONS. International Journal of Legal Developments & Allied Issues. 4, 5 (Oct. 2018), 483–495. DOI:https://doi.org/10.55662/.